76.44
-1.52 (-1.95%)
| Previous Close | 77.96 |
| Open | 77.47 |
| Volume | 3,250,167 |
| Avg. Volume (3M) | 3,781,758 |
| Market Cap | 34,899,599,360 |
| Price / Earnings (TTM) | 15.66 |
| Price / Earnings (Forward) | 16.50 |
| Price / Sales | 1.75 |
| Price / Book | 3.57 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2025 |
| TTM Dividend Yield | 0.18% |
| Profit Margin | 11.03% |
| Operating Margin (TTM) | 14.78% |
| Diluted EPS (TTM) | 4.76 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | 50.80% |
| Total Debt/Equity (MRQ) | 97.51% |
| Current Ratio (MRQ) | 0.980 |
| Operating Cash Flow (TTM) | 1.78 B |
| Levered Free Cash Flow (TTM) | 1.58 B |
| Return on Assets (TTM) | 5.87% |
| Return on Equity (TTM) | 26.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | GE HealthCare Technologies Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | -3.0 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.10 |
|
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%). |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Mid Core |
| % Held by Insiders | 0.28% |
| % Held by Institutions | 80.26% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 93.00 (Citigroup, 21.66%) | Buy |
| Median | 83.50 (9.24%) | |
| Low | 74.00 (Morgan Stanley, -3.19%) | Hold |
| Average | 83.50 (9.24%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 71.32 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 31 Jul 2025 | 93.00 (21.66%) | Buy | 71.32 |
| 09 Jul 2025 | 89.00 (16.43%) | Buy | 75.51 | |
| Morgan Stanley | 31 Jul 2025 | 74.00 (-3.19%) | Hold | 71.32 |
No data within this time range.
| TTM Dividend Yield | 0.18% |
| 2Y Average Dividend Yield | 0.13% |
| Payout Ratio | 2.63% |
| Expected Next Dividend Payment | Feb 2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 25 Jul 2025 | 01 Jul 2025 | 15 Aug 2025 | 0.035 Cash |
| 25 Apr 2025 | 27 Mar 2025 | 15 May 2025 | 0.035 Cash |
| 14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
| 18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
| 19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
| 18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
| 12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
| 19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
| 20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
| 22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.105 | 3 | 0.14 |
| 2024 | 0.120 | 4 | 0.15 |
| 2023 | 0.090 | 3 | 0.12 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |